20.07.2011 • NewsIChemEAstraZenecaawards

IChemE Names AstraZeneca As New Corporate Partner

AstraZeneca, one of the world's largest pharmaceutical companies, has been named as IChemE's newest corporate partner. IChemE President Sir William Wakeham presented senior AstraZeneca personnel with the company's corporate partner certificate last week in front of a gathering of staff, IChemE council members and invited guests.

The company was awarded silver partner status after demonstrating their commitment to the chemical engineering profession and their chemical engineering employees.

Around 100 IChemE members are employed by AstraZeneca in the UK and the company has an IChemE accredited training schemes at its Macclesfield site.

IChemE's corporate partner scheme was launched last year to formally recognize industry employers that demonstrate a sustained commitment to the process industries. The scheme has three tiers and is designed to be flexible enough to recognize industry employers of all sizes.

 

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
21.03.2025 • News

What’s Next for Pharma Supply Chains?

Sudden shifts in demand, supply shortages and global collapse have put immense pressure on pharmaceutical logistics. To address these challenges, PHARMAP 2025 brings together industry experts to discover AI-driven supply chain optimisation, strategic logistics partnerships and digital solutions that enhance efficiency and resilience in the pharmaceutical supply chain.